Low-power laser irradiation (LPLI) promotes VEGF expression and vascular endothelial cell proliferation through the activation of ERK/Sp1 pathway
- 作者：Jie Feng ; Yingjie Zhang ; Da Xing ; xingda@scnu.edu.cn
- 关键词：HUVEC-CS ; human umbilical vein endothelial cells subline ; HEK 293T ; human embryonic kidney 293T ; LPLI ; low-power laser irradiation ; ERK ; extracellular signal-regulated kinase ; Sp1 ; specificity protein 1 ; VEGF ; vascular endothelial growth factor ; EGF ; epid
- 刊名：Cellular Signalling
- 出版年：2012
- 期刊代码：42_08986568
- 类别：bio
- 出版时间：June, 2012
- 卷：24
- 期：6
- 页码：1116-1125
- 文件大小：1446 K
摘要
Angiogenesis, the growth of new blood vessels from pre-existing vessels, represents an excellent therapeutic target for the treatment of wound healing and cardiovascular disease. Herein, we report that LPLI (low-power laser irradiation) activates ERK/Sp1 (extracellular signal-regulated kinase/specificity protein 1) pathway to promote VEGF expression and vascular endothelial cell proliferation. We demonstrate for the first time that LPLI enhances DNA-binding and transactivation activity of Sp1 on VEGF promoter in vascular endothelial cells. Moreover, Sp1-regulated transcription is in an ERK-dependent manner. Activated ERK by LPLI translocates from cytoplasm to nuclear and leads to increasing interaction with Sp1, triggering a progressive phosphorylation of Sp1 on Thr453 and Thr739, resulting in the upregulation of VEGF expression. Furthermore, selective inhibition of Sp1 by mithramycin-A or shRNA suppresses the promotion effect of LPLI on cell cycle progression and proliferation, which is also significantly abolished by inhibition of ERK activity. These findings highlight the important roles of ERK/Sp1 pathway in angiogenesis, supplying potential strategy for angiogenesis-related diseases with LPLI treatment.